+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Delivery Devices Market by Product Type, Therapeutic Area, Technology Platform, Application, End User - Global Forecast 2026-2032- Product Image
Drug Delivery Devices Market by Product Type, Therapeutic Area, Technology Platform, Application, End User - Global Forecast 2026-2032- Product Image
Sale

Drug Delivery Devices Market by Product Type, Therapeutic Area, Technology Platform, Application, End User - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337868
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Delivery Devices Market is projected to reach USD 470.89 Million in 2026. It is expected to continue growing at a CAGR of 8.40%, reaching USD 767.54 Million by 2032.

Drug delivery devices are moving from product features to care-enabling platforms as chronic disease, biologics, and home-based treatment reshape demand. WHO reports that noncommunicable diseases account for about 74% of global deaths, while the International Diabetes Federation estimates 537 million adults were living with diabetes in 2021, creating sustained need for insulin pens, autoinjectors, infusion pumps, inhalers, prefilled syringes, and wearable injectors.

Growth is being driven by patient convenience, dose accuracy, therapy adherence, and the migration of injectable and inhaled therapies outside hospitals. For manufacturers, competitive edge increasingly depends on human factors engineering, connected device capabilities, combination-product compliance, cybersecurity, and scalable global manufacturing.

Transformative Shifts in the Drug Delivery Device Landscape

The drug delivery device landscape is shifting toward self-administration, connected care, and device-drug integration. Biologics and specialty medicines require delivery systems that protect sensitive formulations, enable controlled dosing, and reduce administration burden. At the same time, value-based healthcare is increasing the focus on adherence evidence, real-world outcomes, and reduced total cost of care.

Regulatory expectations are also transforming strategy. FDA combination-product oversight, EU Medical Device Regulation requirements, ISO 11608 standards for needle-based injection systems, and IEC 62304 software lifecycle controls are pushing companies to design safer, more traceable, and more digitally resilient devices.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force across the drug delivery device value chain. AI supports early design simulation, failure-mode analysis, automated visual inspection, predictive maintenance, and signal detection from connected inhalers, pumps, pens, and wearable injectors. These applications can reduce quality variation and accelerate evidence generation when governed by validated data pipelines.

The largest strategic impact will come from AI-enabled personalization, including adherence prediction, dose-support tools, and patient-risk stratification. However, adoption must align with FDA cybersecurity guidance, software as a medical device principles, data privacy rules, and auditable model governance to maintain trust and regulatory defensibility.

Key Regional Insights

Asia-Pacific is advancing on the strength of large diabetic and respiratory patient populations, local manufacturing capacity, and rising access to biologics in China, India, Japan, South Korea, and Australia. WHO identifies Asia-Pacific countries as major contributors to global noncommunicable disease burden, while aging demographics in Japan, South Korea, and China are increasing demand for easy-to-use injectors, inhalers, prefilled syringes, and home-based infusion technologies. North America remains a high-value innovation hub, supported by FDA-regulated combination products, advanced reimbursement pathways, strong clinical trial infrastructure, and demand for connected autoinjectors, insulin pumps, smart inhalers, and wearable injectors.

Europe benefits from established pharmaceutical manufacturing, EU MDR harmonization, strong pharmacovigilance systems, and sustainability expectations for device design, including growing pressure to reduce plastic waste and improve lifecycle management. Latin America is progressing through diabetes care modernization, expanding private-sector access, and broader use of injectable therapies in Mexico and Brazil. The Middle East is investing in specialty care infrastructure, digital health, and chronic disease management programs, particularly across high-income Gulf health systems. Africa remains earlier stage, with opportunities tied to essential medicines access, cold-chain reliability, donor-supported health programs, and affordable device formats suited to decentralized care delivery.

Key Group Insights

ASEAN is becoming more important for manufacturing diversification, medical technology assembly, and diabetes care access, with Singapore, Malaysia, Thailand, Vietnam, Indonesia, and the Philippines supporting regional supply networks and healthcare modernization. The GCC is prioritizing specialty clinics, digital health, and chronic disease programs amid high diabetes and obesity burdens reported across the region, creating demand for premium injectors, connected adherence tools, and hospital-to-home delivery models.

The European Union is shaping global compliance through MDR, sustainability policy, data protection standards, and coordinated health technology assessment priorities. BRICS countries offer scale through large patient pools, localization policies, and expanding domestic medtech capabilities, particularly in China, India, and Brazil. G7 markets lead in reimbursement sophistication, clinical adoption of biologics, regulatory science, and connected drug delivery innovation. NATO economies are increasingly emphasizing supply-chain resilience for critical medicines, polymers, electronics, needles, sensors, and device components as healthcare systems prioritize continuity of access.

Key Country Insights

The United States leads in connected drug delivery innovation, specialty biologics, and FDA-regulated combination products, supported by strong adoption of autoinjectors, insulin pumps, smart inhalers, and digital adherence solutions. Canada emphasizes public coverage, safety, and equitable access, with demand shaped by chronic disease management and alignment with international regulatory expectations. Mexico and Brazil are important Latin American growth markets due to diabetes prevalence, expanding private healthcare, public-sector procurement needs, and regional manufacturing potential. The United Kingdom, Germany, France, Italy, and Spain remain central to European adoption through strong pharmaceutical ecosystems, clinical infrastructure, aging populations, and established pathways for injectable and inhalation therapies.

Russia continues to prioritize local production and supply security, while China and India provide scale, cost competitiveness, expanding domestic device manufacturing, and rising demand for insulin delivery, respiratory drug delivery, and biologic administration systems. Japan and South Korea lead in precision engineering, aging-population needs, digital health readiness, and high-quality device manufacturing. Australia supports advanced care pathways, connected health uptake, chronic disease management programs, and regulatory alignment with international medical device standards, making it a strong reference market for safe, patient-centered drug delivery devices.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize modular drug delivery device platforms that can support multiple formulations, dose volumes, viscosities, and patient populations. Human factors validation, usability for elderly patients, needle-safety features, low-force activation, dose confirmation, and minimized administration steps should be embedded early to reduce development risk and improve adoption.

Companies should also invest in connected-device cybersecurity, AI governance, sustainable materials, supplier redundancy, and localized regulatory strategies. Partnerships with pharmaceutical developers, contract manufacturers, digital health specialists, healthcare providers, and patient-support programs can accelerate evidence generation, improve adherence, strengthen market access, and support lifecycle differentiation without compromising safety or compliance.

Research Methodology

This executive summary is grounded in secondary research from recognized public sources, including WHO, International Diabetes Federation, FDA, EMA, ISO, IEC, OECD, World Bank, and national regulatory agencies. Insights were structured around disease burden, device innovation, regulatory standards, healthcare delivery trends, regional market maturity, chronic disease management, and the adoption of self-administration technologies.

The analysis applies triangulation across regulatory publications, clinical-care trends, demographic datasets, reimbursement signals, public health indicators, and supply-chain evidence. Emphasis was placed on verified directional evidence rather than unsupported market-size, market-share, or forecast claims, ensuring that conclusions remain credible for strategic planning and industry intelligence.

Conclusion

The drug delivery devices market is entering a platform-driven era defined by self-administration, connected monitoring, biologics delivery, and AI-supported lifecycle management. Demand is supported by chronic disease prevalence, aging populations, expanding specialty therapeutics, and the need for convenient, accurate, and scalable treatment delivery across hospital, clinic, and home-care settings.

Winning organizations will combine regulatory discipline with patient-centered design, resilient manufacturing, digital security, sustainable engineering, and region-specific commercialization. As healthcare systems shift care closer to the patient, drug delivery devices will remain central to improving adherence, outcomes, treatment continuity, and access.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Drug Delivery Devices Market, by Product Type
7.1. Injection Devices
7.1.1. Syringes
7.1.2. Pen Injectors
7.1.2.1. Disposable Pen Injectors
7.1.2.2. Reusable Pen Injectors
7.1.3. Autoinjectors
7.1.4. Needle-Free Injectors
7.2. Infusion Devices
7.2.1. External Infusion Pumps
7.2.1.1. Insulin Pumps
7.2.1.2. Ambulatory Infusion Pumps
7.2.2. Implantable Infusion Pumps
7.3. Inhalation Devices
7.3.1. Metered Dose Inhalers
7.3.2. Dry Powder Inhalers
7.3.3. Nebulizers
7.3.3.1. Jet Nebulizers
7.4. Transdermal Delivery Devices
7.5. Implantable Devices
8. Drug Delivery Devices Market, by Therapeutic Area
8.1. Metabolic Disorders
8.2. Oncology
8.2.1. Solid Tumors
8.2.2. Hematologic Malignancies
8.3. Cardiovascular Diseases
8.3.1. Hypertension
8.3.2. Heart Failure
8.4. Respiratory Diseases
8.5. Autoimmune And Inflammatory Diseases
8.6. Infectious Diseases
8.6.1. Viral Infections
8.6.2. Bacterial Infections
8.7. Neurological Disorders
8.8. Pain Management
8.9. Hormonal Disorders
9. Drug Delivery Devices Market, by Technology Platform
9.1. Mechanical Delivery Systems
9.2. Electromechanical Devices
9.3. Biodegradable Polymer Systems
10. Drug Delivery Devices Market, by Application
10.1. Diabetes
10.2. Oncology
10.3. Cardiovascular diseases
10.4. Pain management
11. Drug Delivery Devices Market, by End User
11.1. Hospitals
11.2. Clinics
11.3. Ambulatory Surgical Centers
11.4. Home Care Settings
11.5. Diagnostic Centers
12. Asia-Pacific Drug Delivery Devices Market
13. Europe Drug Delivery Devices Market
14. North America Drug Delivery Devices Market
15. Latin America Drug Delivery Devices Market
16. Africa Drug Delivery Devices Market
17. Middle East Drug Delivery Devices Market
18. NATO Drug Delivery Devices Market
19. G7 Drug Delivery Devices Market
20. BRICS Drug Delivery Devices Market
21. European Union Drug Delivery Devices Market
22. ASEAN Drug Delivery Devices Market
23. GCC Drug Delivery Devices Market
24. China Drug Delivery Devices Market
25. United States Drug Delivery Devices Market
26. Japan Drug Delivery Devices Market
27. India Drug Delivery Devices Market
28. Germany Drug Delivery Devices Market
29. United Kingdom Drug Delivery Devices Market
30. Australia Drug Delivery Devices Market
31. France Drug Delivery Devices Market
32. South Korea Drug Delivery Devices Market
33. Italy Drug Delivery Devices Market
34. Canada Drug Delivery Devices Market
35. Russia Drug Delivery Devices Market
36. Brazil Drug Delivery Devices Market
37. Mexico Drug Delivery Devices Market
38. Spain Drug Delivery Devices Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. AdminMed nanoBioSciences LLC
40.2. AptarGroup, Inc.
40.3. ARx, LLC
40.4. Bayer AG
40.5. BioSerenTach Inc.
40.6. CosMED Pharmaceutical Co., Ltd.
40.7. Credence MedSystems, Inc.
40.8. E3D Elcam Drug Delivery Devices
40.9. Innoture Medical Technology Limited
40.10. Kindeva Drug Delivery L.P.
40.11. Luye Pharma Group?
40.12. Medtronic, Inc.
40.13. Midas Pharma GmbH
40.14. NanoPass Technologies Ltd.
40.15. Nitto Denko Corporation
40.16. Novartis AG?
40.17. Owen Mumford Limited
40.18. Recipharm AB
40.19. Sparsha Pharma International Pvt. Ltd.
List of Figures
FIGURE 1. GLOBAL DRUG DELIVERY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DRUG DELIVERY DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL DRUG DELIVERY DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL DRUG DELIVERY DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2032 (%)
FIGURE 17. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2032 (%)
FIGURE 19. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 23. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. CHINA DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. INDIA DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. GERMANY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. UNITED KINGDOM DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. AUSTRALIA DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. FRANCE DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. SOUTH KOREA DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. ITALY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CANADA DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. RUSSIA DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. BRAZIL DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. MEXICO DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SPAIN DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DRUG DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL INJECTION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL INJECTION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL SYRINGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SYRINGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PEN INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PEN INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PEN INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DISPOSABLE PEN INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DISPOSABLE PEN INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DISPOSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL REUSABLE PEN INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL REUSABLE PEN INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL REUSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL AUTOINJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL AUTOINJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL NEEDLE-FREE INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL INFUSION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL INFUSION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL EXTERNAL INFUSION PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL EXTERNAL INFUSION PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL EXTERNAL INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL INSULIN PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL INSULIN PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL AMBULATORY INFUSION PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL AMBULATORY INFUSION PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL AMBULATORY INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IMPLANTABLE INFUSION PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IMPLANTABLE INFUSION PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL IMPLANTABLE INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL INHALATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL INHALATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL INHALATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL METERED DOSE INHALERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL METERED DOSE INHALERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL METERED DOSE INHALERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DRY POWDER INHALERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DRY POWDER INHALERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DRY POWDER INHALERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL NEBULIZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL NEBULIZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL JET NEBULIZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL JET NEBULIZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL JET NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL TRANSDERMAL DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL TRANSDERMAL DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL TRANSDERMAL DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL SOLID TUMORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL SOLID TUMORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL SOLID TUMORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL HYPERTENSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL HYPERTENSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL HYPERTENSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL HEART FAILURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL HEART FAILURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL HEART FAILURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL AUTOIMMUNE AND INFLAMMATORY DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL AUTOIMMUNE AND INFLAMMATORY DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL AUTOIMMUNE AND INFLAMMATORY DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL HORMONAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL HORMONAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL HORMONAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL MECHANICAL DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL MECHANICAL DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL MECHANICAL DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ELECTROMECHANICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ELECTROMECHANICAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ELECTROMECHANICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BIODEGRADABLE POLYMER SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL BIODEGRADABLE POLYMER SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL BIODEGRADABLE POLYMER SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL DIABETES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 168. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 169. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
TABLE 170. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
TABLE 171. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 172. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
TABLE 173. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
TABLE 174. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 175. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 176. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 177. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 178. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 179. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 180. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 182. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 183. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 184. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
TABLE 185. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
TABLE 186. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 187. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
TABLE 188. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
TABLE 189. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 190. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 191. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 192. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 193. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 194. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 197. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 198. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 199. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
TABLE 200. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
TABLE 201. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 202. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
TABLE 203. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
TABLE 204. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 205. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 206. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 207. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 208. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 209. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 210. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 212. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 213. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 214. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
TABLE 215. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
TABLE 216. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 217. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
TABLE 218. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
TABLE 219. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 220. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 221. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 222. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 223. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 224. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 227. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 228. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 229. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
TABLE 230. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
TABLE 231. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 232. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
TABLE 233. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
TABLE 234. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 235. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 236. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 237. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 238. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 239. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 240. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 242. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 243. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 244. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
TABLE 245. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
TABLE 246. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 247. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
TABLE 248. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
TABLE 249. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 250. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 251. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 252. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 253. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 254. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 255. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 257. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 258. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 259. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
TABLE 260. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
TABLE 261. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 262. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
TABLE 263. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
TABLE 264. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 265. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 266. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 267. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 268. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 269. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 270. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 271. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 272. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 273. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 274. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
TABLE 275. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
TABLE 276. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 277. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
TABLE 278. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
TABLE 279. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 280. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 281. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 282. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 283. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 284. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 285. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
TABLE 294. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 295. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 297. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 298. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 301. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 302. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 303. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 304. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
TABLE 305. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
TABLE 306. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 307. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
TABLE 308. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
TABLE 309. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 310. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 311. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 312. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 313. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 314. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 315. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 316. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 317. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 318. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 319. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
TABLE 320. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
TABLE 321. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 322. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
TABLE 323. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
TABLE 324. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 325. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 326. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 327. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 328. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 329. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 330. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 331. CHINA DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 332. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 333. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 334. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
TABLE 335. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
TABLE 336. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 337. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
TABLE 338. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
TABLE 339. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 340. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 341. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 342. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 343. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 344. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 345. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 346. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 347. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 348. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 349. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
TABLE 350. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
TABLE 351. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 352. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
TABLE 353. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
TABLE 354. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MI

Companies Mentioned

The companies featured in this Drug Delivery Devices market report include:
  • AdminMed nanoBioSciences LLC
  • AptarGroup, Inc.
  • ARx, LLC
  • Bayer AG
  • BioSerenTach Inc.
  • CosMED Pharmaceutical Co., Ltd.
  • Credence MedSystems, Inc.
  • E3D Elcam Drug Delivery Devices
  • Innoture Medical Technology Limited
  • Kindeva Drug Delivery L.P.
  • Luye Pharma Group​
  • Medtronic, Inc.
  • Midas Pharma GmbH
  • NanoPass Technologies Ltd.
  • Nitto Denko Corporation
  • Novartis AG​
  • Owen Mumford Limited
  • Recipharm AB
  • Sparsha Pharma International Pvt. Ltd.

Table Information

Report AttributeDetails
No. of Pages182
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 470.89 Million
Forecasted Market Value ( USD ) by 2032 $ 767.54 Million
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Connected Drug Delivery Devices Market - Global Forecast 2026-2032 - Product Image

Connected Drug Delivery Devices Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Cell & Gene Therapy Drug Delivery Devices Market - Global Forecast 2026-2032 - Product Image

Cell & Gene Therapy Drug Delivery Devices Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Drug Delivery Devices Market Report and Forecast 2025-2034 - Product Image

Drug Delivery Devices Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Connected Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Connected Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.